A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
Clinical trial NCT02019329 · COMPLETED
Trial details
- NCT number
- NCT02019329
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.